Oslo, Norway —Kappa Bioscience has launched a free vitamin K2 MK-7 quality testing program, which it announced at CPhI India. This will allow for testing and verification of any finished K2 product’s K2 label claim.
A goal of this program is to educate markets about K2 stability and how unprotected K2 is unstable in mineral formulations, the company said.
Test results will only be reported to the test requester after being conducted using USP methods. Stakeholders for vitamin K2 products are invited to send samples for this free assessment.
‘‘We view independently-validated testing programs as an innovative way to address quality issues in the K2 market, if not the supplements industry as a whole,’’ said Egil Greve, CEO of Kappa Bioscience in a press release. He goes on to explain “this program says, ‘don’t trust our data, or anyone else’s. Trust your own data for your own products.’ We hope to make this easier to do.’’
The program is managed by the independent group Kappa Chemistry with validation conducted by globally recognized third-party laboratories in Europe, USA and Australia. As results will remain confidential to the requester, general results excluding brand identifiers will be included in Kappa’s annualK2 Market Study.
For more information on how to participate in the K2 testing program visitwww.Kappabio.com.
